a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients
- Conditions
- Chronic Kidney Disease Requiring Chronic Dialysis
- Interventions
- Other: Diet containing inorganic phosphateOther: Diet containing organic phosphate
- Registration Number
- NCT04600193
- Lead Sponsor
- University of Copenhagen
- Brief Summary
Hyperphosphatemia is a common problem among patientens suffering from chronic kidney disease. Hyperphosphatemia is associated with increased risk of cardiovascular diseases. One of the treatments are through the diet, where patients are instructed ind reducing their daily intake of phosphate. But since phosphate exists in both organic and inorganic forms in the diet, this leads to several problems. Informations of the bioavability and furthermore the effect of plasma koncentrations of phosphate are lacking for both forms of phosphate.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 21
- Patients > 18 years
- Competent
- The patient should be able to take a sample of p-fluid and urine by himself
- Chronic peritoneal dialysis
- Reads and understand danish
- Has been informed written and oraly about the study and signed informed consent
- P-phosphate koncentrations 0,7-2,0 .mol/l
- P - ioniset calcium 1,1-1,4 mmol/l
- Pregnant or breast-feeding
- Terminal patients
- If the experience acute infections or other acute situations they will be excluded from the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Phosphate modified diet with inorganic phosphate Diet containing inorganic phosphate - Phosphate modified diet with organic phosphate Diet containing organic phosphate -
- Primary Outcome Measures
Name Time Method Plasma levels of phosphate six days
- Secondary Outcome Measures
Name Time Method Changes in p-potassium six days Koncentration of phosphate in urine six days Changes in p-sodium six days Changes in p-magnesium six days changes in p-calcium six days Koncentration of phosphate in peritoneal dialysis fluid six days Changes in p-phosphate six days changes in p-PTH six days Changes in p-FGF23 six days
Trial Locations
- Locations (1)
Herlev Hospital
🇩🇰Herlev, Denmark